Amphastar Pharmaceuticals, Inc. (AMPH) financial statements (2020 and earlier)

Company profile

Business Address 11570 SIXTH STREET
RANCHO CUCAMONGA, CA 91730
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments988968736668
Cash and cash equivalents868666726668
Short-term investments13331  
Restricted cash and investments444111
Receivables455236273323
Inventory, net of allowances, customer advances and progress billings1106964807182
Inventory1106964807182
Deferred tax assets    20
Other undisclosed current assets11616354
Total current assets:269220188184176198
Noncurrent Assets
Property, plant and equipment222210185153142138
Intangible assets, net (including goodwill), including:414245504043
Goodwill444444
Intangible assets, net (excluding goodwill)891117738
Other undisclosed intangible assets, net (including goodwill)29292929290
Other noncurrent assets12109954
Deferred tax assets, net2131283127 
Other undisclosed noncurrent assets20    7
Total noncurrent assets:317293267244214191
TOTAL ASSETS:586514455428390389
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities758758534738
Accounts payable223117161410
Accrued liabilities535641161713
Employee-related liabilities   141311
Taxes payable   833
Debt71865118
Deferred revenue and credits  114
Deferred tax liabilities    1
Other undisclosed current liabilities413222
Total current liabilities:8710767616063
Noncurrent Liabilities
Long-term debt and lease obligation, including:383241323036
Long-term debt, excluding current maturities 4946364043
Other undisclosed long-term debt and lease obligation38(17)(5)(4)(10)(7)
Liabilities, other than long-term debt10109448
Deferred revenue and credits 012
Accounts payable and accrued liabilities001100
Deferred tax liabilities, net1111 6
Other liabilities99722 
Other undisclosed noncurrent liabilities17  110
Total noncurrent liabilities:654250383545
Total liabilities:1521491179895108
Stockholders' equity
Stockholders' equity attributable to parent389332337329296282
Common stock000000
Treasury stock, value(84)(75)(51)(20)(10)(0)
Additional paid in capital362344314283248221
Accumulated other comprehensive loss(6)(4)(2)(5)(2)(2)
Retained earnings1176776716063
Stockholders' equity attributable to noncontrolling interest4432    
Total stockholders' equity:434364337329296282
TOTAL LIABILITIES AND EQUITY:586514455428390389

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues329295240255252210
Revenue, net240255252210
Cost of revenue(195)(188)(149)(151)(174)(159)
Gross profit:133107911047751
Operating expenses(131)(116)(92)(88)(84)(69)
Operating income (loss):2(9)(1)16(7)(18)
Nonoperating income (expense)58(1)3(1)(3)(0)
Investment income, nonoperating100000
Other nonoperating income (expense)57(2)30(3)0
Interest and debt expense(0)(0)(1)(1)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes     1
Income (loss) from continuing operations before equity method investments, income taxes:60(10)114(11)(18)
Other undisclosed income from continuing operations before income taxes00111 
Income (loss) from continuing operations before income taxes:60(10)215(10)(18)
Income tax expense (benefit)(12)33(4)87
Net income (loss):47(7)511(3)(11)
Net income attributable to noncontrolling interest41    
Net income (loss) available to common stockholders, diluted:52(6)511(3)(11)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):47(7)511(3)(11)
Other comprehensive loss     (2)
Comprehensive income (loss):47(7)511(3)(12)
Comprehensive income, net of tax, attributable to noncontrolling interest41    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2)(2)3(2)(1) 
Comprehensive income (loss), net of tax, attributable to parent:50(8)78(4)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: